Why the study?
What are the prognostic factors for survival after pulmonary metastasectomy in patients with osteosarcomas of the extremities?
What are the prognostic factors for survival after pulmonary metastasectomy in patients with osteosarcomas of the extremities?
In patients with pulmonary metastases from extremity osteosarcoma, having fewer than five metastases and no new metastases during perioperative chemotherapy are associated with better survival after metastasectomy.
Answers are grounded in this paper and cite their sources.
May inform selection for pulmonary metastasectomy in extremity osteosarcoma; leaves open whether it improves outcomes.
BACKGROUND: Factors affecting recurrence and survival after pulmonary resection for metastatic osteosarcomas are controversial. To confirm a role for resection of pulmonary metastases for such tumors, we herein reviewed our institutional experience. METHODS: Between 1989 and 2007, 23 patients with pulmonary metastases from osteosarcomas of the extremities underwent pulmonary resection. Various perioperative variables were investigated retrospectively to confirm a role for metastasectomy and to analyze prognostic factors for overall survival and disease-free survival after metastasectomy. RESULTS: Overall survival rate after metastasectomy was 31% at 5 years. Disease-free survival rate was 19% at 5 years after pulmonary resection. On multivariate analysis, patients with less than five pulmonary metastases and patients without pulmonary metastases identified during pre- and postoperative chemotherapy presented significantly favorable overall survival (p=0.015 and 0.0082, respectively). Furthermore, the number of pulmonary metastases less than five was the only significantly favorable prognostic factor for disease-free survival on univariate analysis (p=0.0055). CONCLUSIONS: Current practice of pulmonary metastasectomy for osteosarcomas in our institution was well justified. The number of pulmonary metastases more than five and the advent of pulmonary metastases during pre- and postoperative chemotherapy seemed relevant to a worse prognosis.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: